Clinical significance of preoperative injection of carbon nanoparticles by endoscope in laparoscopic

来源 :第十三届全国胃癌学术会议 | 被引量 : 0次 | 上传用户:wangluojishu0802
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective To compare the effect of carbon nanoparticles on the number of lymph node dissection and prognosis of gastric cancer,and explore its clinical significance in laparoscopic radical gastrectomy.
其他文献
Objective Robotic-assisted gastrectomy(RAG)has been rapidly adopted for gastric cancer(GC)treatment.However,whether RAG provides any significant outcome/cost advantages over laparoscopy-assisted gastr
Objective Robotic gastrectomy(RG)is a new surgical method alternative for gastric cancer.However,few studies have evaluated the outcomes of RG for advanced gastric cancer(AGC).
Objective Robot-assisted gastrectomy(RAG)is a technically feasible and safe procedure in treating gastric cancer(GC).However,concern about oncological radicality and long-term outcomes has limited the
Objective Comparison of robotic and laparoscopic assisted gastrectomy in advanced gastric cancer: updated short-and long-term results Emerging evidence has demonstrated laparoscopic-assisted gastrecto
Objective The objective of the study is to present the clockwise and modularized lymphadenectomy model of laparoscopic gastrectomy for gastric cancer patients,which is based on our ten-year clinical p
Objective The 8th TNM classification for gastric cancer separates the final pathological stage of pN3 into pN3a and pN3b.The cutoff that separates pN3a/pN3b is defined as 15 metastatic lymph nodes,but
目的 目的 比较3D 腹腔镜根治性全胃切除术与传统2D 腹腔镜根治性全胃切除术对区域淋巴结清扫及并发症的影响。方法 选择2015 年3 月至2017 年11 月在福建省肿瘤医院行腹腔镜根治性全胃切除的268 例患者的临床病理资料。
目的 胃窦、胃体癌中第2 组淋巴结属于第3 站淋巴结,胃癌手术淋巴结清扫中常不受重视。笔者术中发现多数胃窦、胃体癌患者伴有第2 组淋巴结肿大,遂进行清扫,对术后病理结果进行统计分析,探讨胃窦、胃体癌患者第2 组淋巴结的转移发生率及其影响因素。
目的 分析并探讨近端胃癌(PGC)患者中NO.5 和NO.6 淋巴结转移情况及相关危险因素.方法 回顾性分析上海交通大学医学院附属瑞金医院于2014.09.30 至2017.12.21 收治的PGC患者的临床资料,排除术前接受新辅助放化疗的患者后纳入292 例数据.
目的 在D2 手术的基础上,探索D3 手术能否使进展期胃癌患者获益。方法 回顾性分析2006 年11 月至2011 年12 月期间在中山大学孙逸仙纪念医院接受胃癌根治术的577 例进展期胃癌患者资料,其中458 例患者接受D2 手术,119 例患者接受D3 手术。主要研究终点为5 年总体生存期。